Search earnings tickers

VRTX

2025Q3AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-11-03 · Fiscal end 2025-09-30 · Features as of 2025-11-03

← Earnings history

Street

Consensus EPS4.58

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2025-11-03

Run-up

Close—

Ret 5d+1.4%

Ret 10d+1.6%

Ret 20d+5.7%

Ret 30d+11.2%

Print

Actual EPS

4.80Beat

Estimated EPS4.58

Actual revenue

3.1B

Surprise %+4.8%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction+0.7%

Implied vs actual

Implied 2.4%Actual 1.7%

Gap reaction-1.7%

Day result-1.0%

Next-day upYes

Realized / IV0.72×

Post tape

Post 5d+1.8%

Post 10d+3.3%

Post volume2.4M

Vol ×10d1.69×

Vol ×20d1.80×

Post range6.6%